Animal models of psoriasis

Bibliography

• NICKOLOFF BJ: Cytokine network in psoriasis. Arch. Dermatol. (1991) 131:1–10.
   Google Scholar
• OZAWA A, OHKIDO M, INOKO H, ANDO A, TSUJI K: Spe-cific restriction fragment length polymorphism on the HLA-C region and susceptibility to psoriasis. J. In-vest. Dermatol. (1988) 90:402–405.
   PubMed Web of Science ®Google Scholar
• SAKKAS LI, LOQUEMAN N, BIRD H et al.: HLA class II and T cell receptor gene polymorphisms in psoriatic ar-thritis and psoriasis. J. Rheumatol. (1990) 17:1487–1490.
   PubMed Web of Science ®Google Scholar
• ASAHINA A, AKAZAKI S, NAKAGAWA H et al.: Specific nu-cleotide sequence of HLA-C is strongly associated with psoriasis vulgaris. J. Invest. Dermatol. (1991) 97:254–258.
   PubMed Web of Science ®Google Scholar
• TOMFOHRDE J, SILVERMAN A, BARNES R et al.: Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science (1994) 264:1141–1145.
   PubMed Web of Science ®Google Scholar
• NAIR RP, GUO SW, JENISCH S et al.: Scanning chromo-some 17 for psoriasis susceptibility: lack of evidence for a distal 17q locus. Hum. Hered. (1995) 45:219–230.
   PubMed Web of Science ®Google Scholar
• MATHEWS D, FRY L, POWLES A et al.: Evidence that a lo-cus for familial psoriasis maps to chromosome 4q. Na-ture Genet. (1996) 14:231–233.
   PubMed Web of Science ®Google Scholar
• HARDAS DB, ZHAO X, ZHANG J et al.: Assignment of psoriasin to human chromosomal band 1q21: coordi-nate overexpression of clustered genes in psoriasis. J. Invest. Dermatol. (1996) 106:753–758.
   PubMed Web of Science ®Google Scholar
• TREMBATH RC, CLOUGH RL, ROSBOTHAM JL et al.: Iden-tification of a major susceptibility locus on chromo-some 6p and evidence for further disease loci revealed by two stage genome-wide search in psoriasis. Human Mol Genetics (1997) 6:813–820.
   PubMed Web of Science ®Google Scholar
• HOHLER T, KRUGER A, SCHNEIDER PM et al.: A TNF-apromoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis. J. Invest. Derma-tol. (1997) 109:562–565.
   PubMed Web of Science ®Google Scholar
• NAIR RP, HENSELER T, JENISCH S et al.: Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum. Mol. Genet. (1997) 6:1349–1356.
   PubMed Web of Science ®Google Scholar
• CAPON F, NOVELLI G, SEMPRINI S et al.: Searching for psoriasis susceptibility genes in Italy: genome scan and evidence for a new locus on chromosome 1.j In-vest. Dermatol. (1999) 112:32.
   Google Scholar
• PARK BS, PARK JS, LEE DY, YOUN JI, KIM IG: Vitamin D receptor polymorphism is associated with psoriasis. J. Invest. Dermatol. (1999) 112:113–116.
   PubMed Web of Science ®Google Scholar
• FARBER EM, NALL LM: The natural history of psoriasis in 5,600 patients. Dermatologica (1974) 148:1–18.
   PubMedGoogle Scholar
• GOTTLIEB AB: Immunopathogenesis of psoriasis. Arch. Dermatol. (1997) 33:781–787.
   Google Scholar
• BARKER JNWN: The pathophysiology of psoriasis. Lan-cet (1997) 338:227–230.
   Google Scholar
• STERN RS: Psoriasis. Lancet (1997) 350:349–353.
   PubMed Web of Science ®Google Scholar
• GOTTLIEB SL, GILLEAUDEAU P, JOHNSON R et al: Re-sponse of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not kera-tinocyte, pathogenic basis. Nature Med. (1995) 1:442–447.
   PubMed Web of Science ®Google Scholar
• NICKOLOFF BJ: Psoriasis - mediation of skin pheno-type by circulatory pathogenic T lymphocytes. In: Strategies for Immunointervention in Dermatology. G Burg, R Dummer (Eds.), Springer-Verlag, Heidelberg, Germany (1997):253–262.
   Google Scholar
• WRONE-SMITH T, NICKOLOFF BJ: Dermal injection of immunocytes induces psoriasis. J. Clin. Invest. (1996) 98:1878–1887.
   PubMed Web of Science ®Google Scholar
• KRUEGER GG, MANNING DD, MALOUF J, OGDEN B: Long-term maintenance of psoriatic human skin on congenitally athymic (nude) mice. J. Invest. Dermatol. (1975) 64:307–312.
   PubMed Web of Science ®Google Scholar
• BRIGGAMAN RA, WHEELER CE: Nude mouse-human skin graft model III. Studies on generalized psoriasis. J. Invest. Dermatol. (1976) 74:262.
   Google Scholar
• HAFTEK M, ORTONNE JP, STAQUET MJ, VIAC J, THIVO-LET J: Normal and psoriatic human skin grafts on 'nude' mice: morphological and immunochemical studies. J. Invest. Dermatol. (1981) 76:48–52.
   PubMed Web of Science ®Google Scholar
• KRUEGER GB, CHAMBERS DA, SHELBY J: Involved andenvironmental skin from psoriatic subjects: are they equally diseased? Assessment by skin transplanted to cogenitally athymic (nude) mice. J. Clin. Invest. (1981) 68:1548–1557.
   PubMed Web of Science ®Google Scholar
• FRAKI JE, BRIGGAMAN RA, LAZARUS GS: Univolved skinfrom psoriatic patients develop signs of involved skin after being grafted onto nude mice. Science (1982) 215:685–687.
   PubMed Web of Science ®Google Scholar
• FRAKI JE, BRIGGAMAN RA, LAZARUS GS: Transplanta-tion of psoriatic skin onto nude mice. J. Invest. Derma-tol (1983) 80 (Suppl.):31s–35s.
   Google Scholar
• POWLES AV, BRENT L, BAKER B, VALDIMARSSON H, WALKER M, FRY L: Transplantation of psoriatic skin onto nude athymic mice does not maintain features of psoriasis. J. Invest. Dermatol (1989) 93:306.
   Web of Science ®Google Scholar
• BAKER BS, BRENT L, VALDIMARSSON H: Is epidermalcell proliferation in psoriatic skin grafts on nude mice driven by T cell derived cytokines? Br. J. Dermatol (1992) 126:105–111.
   Web of Science ®Google Scholar
• BOEHNCKE W, STERRY W, HAINZE A, SCHEFFOLD W,KAUFMAN R: Psoriasiform architecture of murine epi-dermis overlying human psoriatic dermis trans-planted onto SCID mice. J. Cut. Pathol. (1994) 286:325–330.
   Google Scholar
• NICKOLOFF BJ, KUNKEL SL, BURDICK M, STREITER RM:Severe combined immunodeficiency mouse and hu-man psoriatic skin chimeras. Validation of a new ani-mal model. Am. J. Pathol. (1995) 146:580–588.
   PubMed Web of Science ®Google Scholar
• BOEHNCKE WH, DRESSEL D, ZOLLNER TM, KAUFMANNR: Pulling the trigger on psoriasis. Nature (1996) 379:777.
   PubMed Web of Science ®Google Scholar
• GILHAR A, DAVID M, ULLMANN Y, BERKUTSKI T, KALISH RS: T-lymphocyte dependence of psoriatic pathology in human psoriatic skin grafted to SCID mice. J. Invest. Dermatol. (1997) 109:283–288.
   PubMed Web of Science ®Google Scholar
• NICKOLOFF BJ, WRONE-SMITH T: Superantigen, auto-antigens, and pathogenic T cells in psoriasis. J. Invest. Dermatol. (1998) 110:459–460.
   PubMed Web of Science ®Google Scholar
• YAMAMOTO T, MATSUUCHI M, KATAYAMA I, NISKIOKAK: Repeated subcutaneous injection of staphyloccal enterotoxin B- stimulated lymphocytes retain epider-mal thickness of psoriatic skin-graft onto severe com-bined immunodeficient mice. J. Dermatol. Sci. (1998) 17:8–14.
   PubMed Web of Science ®Google Scholar
• SUGAI J, IIZUKA M, OZAWA A, SHIMAMUR K: Histologi-cal and immunohistochemical studies of human pso-riatic lesions transplanted onto SCID mice. J. Dermatol Sci. (1998) 17:85–92.
   PubMed Web of Science ®Google Scholar
• NICKOLOFF BJ, WRONE-SMITH T, BONISH B, PORCELLISA: Response of murine and normal human skin to in-jection of allogeneic blood-derived psoriatic immuno-cytes: detection of T cells expressing receptors typically present on natural killer cells including CD94, CD158, and CD161. Arch. Dermatol. (1999). (In press).
   Google Scholar
• NICKOLOFF BJ: Pathogenesis and immunointerven-tion strategies in psoriasis. Mol. Med. Today (1998) 4:512–513.
   PubMedGoogle Scholar
• NICKOLOFF BJ: The immunologic and genetic basis ofpsoriasis. (1999). (Submitted).
   Google Scholar
• DAM TS, KANG S, NICKOLOFF BJ: Pharmacological modulation of induction and treatment of psoriasis us-ing human skin grafted onto SCID mice. J. Invest. Der-matol. (1997) 108:572.
   Google Scholar
• ASADULLAH K, STERRY W, STEPHANEK K et al.: IL-10 is akey cytokine in psoriasis. J. Clin. Invest. (1998) 101:783–794.
   PubMed Web of Science ®Google Scholar
• ELLIAS PM, HOLLERAN WM, FEINGOLD KR et al.: Normalmechanisms and pathophysiology of epidermal bar-rier homeostasis. Curr. Opin. Dermatol. (1993) 16:231–237.
   Google Scholar
• NICKOLOFF BJ, NAIDU Y: Perturbation of epidermalbarrier function correlates with initiation of cytokine cascades in human skin. J. Am. Acad. Dermatol (1994) 30:535–546.
   PubMed Web of Science ®Google Scholar
• FOREMAN KE, FRIBORG J, NABEL G, NICKOLOFF BJ: In-jection of HHV-8 in human skin engrafted on SCID mice induces Kaposi's sarcoma-like lesions. J. Invest. Dermatol. (1998) 110:473.
   Web of Science ®Google Scholar
• NICKOLOFF BJ, MITRA RS, VARANI J, DIXIT VM, POLVER-INI PJ: Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes medi-ates angiogenesis. Am. J. Pathol. (1994) 144:820–828.
   PubMed Web of Science ®Google Scholar
• ROTHNAGEL JA, GREENLAULGH DA, WANG XJ et al: Transgenic models of skin diseases. Arch. Dermatol. (1993) 129:1430–1436.
   PubMed Web of Science ®Google Scholar
• NICKOLOFF BJ, WRONE-SMITH T: Animal models of psoriasis. Nature Med. (1997) 3:475–476.
   PubMed Web of Science ®Google Scholar
• WILSON JB, WEINBERG W, JOHNSON R, YUSPA S, LEVINE AJ: Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperpla-sia and aberrant expression of keratin 6. Cell (1990) 61:1315–1327.
   PubMed Web of Science ®Google Scholar
• MANN GB, FOWLER KJ, GABRIEL A et al.: Mice with a null mutation of the TGF-a gene have abnormal skin archi-tecture, wavy hair, and curly whiskers and often de-velop corneal inflammation. Cell (1993) 73:249–261.
   PubMed Web of Science ®Google Scholar
• TURKSEN K, KUPPER T, DEGENSTEIN L, WILLIAMS I, FUCHS E: Interleukin 6: insights to its function by over-expression in transgenic mice. Proc. Natl. Acad. ScL USA (1992) 89:5068–5072.
   PubMed Web of Science ®Google Scholar
• GUO L, YU QC, FUCHS E: Targeting expression of kera-tinocyte growth factor to keratinocytes elicits striking changes in epithelial differentiation in transgenic mice. EMBO J (1993) 12:973–986.
   PubMed Web of Science ®Google Scholar
• GROVES RW, MIZUTANI H, KEIFFER JD, KUPPER TS: In-flammatory skin disease in transgenic mice that ex-press high levels of interleukin la in basal epidermis. Proc. Natl. Acad. ScL USA (1995) 92:11874–11878.
   PubMed Web of Science ®Google Scholar
• WILLIAMS JR, KUPPER TS: Epidermal expression of in-tercellular adhesion molecule 1 is not a primary in-ducer of cutaneous inflamation in transgenic mice. Proc. Natl. Acad. ScL USA(1994) 91:9710–9714.
   PubMed Web of Science ®Google Scholar
• KLEMENT JF, RICE NR, CAR BD et al: bcBa deficiency re-sults in a sustained NF-K13 response and widespread dermatitis in mice. Mol Cell. Biol. (1996) 16:2341–2349.
   PubMed Web of Science ®Google Scholar
• SEITZ CS, LIN Q, DENG H, KHAVARI PA: Alterations on NF-KB function in transgenic epithelial tissue demon-strates a growth inhibitory role for NF-KB. Proc. Nat. Acad. ScL USA (1998) 95:2307–2312.
   PubMed Web of Science ®Google Scholar
• BLESSING M, SCHIRMACHER P, KAISER S: Overexpres-sion of bone morphogenic protein-6 (BMP-6) in the epidermis of transgenic mice: inhibition or stimula-tion of proliferation depending on the pattern of transgene expression and formation of psoriatic le-sions. J. Cell Biol. (1996) 135:227–239.
   PubMedGoogle Scholar
• PENA JC, FUCHS E, THOMPSON CB: Bcl-x expression in-fluences cell survival but not terminal differentiation. Cell Growth Differ. (1997) 8:619–627.
   PubMedGoogle Scholar
• RODRIGUEZ-VILLANUEVA J, GREENHALH D, WANG X-J et al.: Human keratin-1 period bc1-2 mice aberrantly ex-press keratin 6, exhibit reduced sensitivity to keratino-cyte cell death induction, and are susceptible to skin tumor formation. Oncogene (1998) 16:853–863.
   PubMed Web of Science ®Google Scholar
• COOK PW, PIEPKORN M, CLEGG CH: Transgenic expres-sion of the human amphiregulin gene induces a psoriasis-like phenotype. J. Clin. Invest. (1997) 100:2286–2294
   PubMed Web of Science ®Google Scholar
• ROBLES AJ, LARCHER F, WHALIN RB et al.: Expression ofcyclin D1 in epithelial tissue of transgenic mice results in epidermal hyperproliferation and severe thymic hyperplasia. Proc. NatI Acad. ScL USA(1996) 93:7634–7638.
   PubMed Web of Science ®Google Scholar
• CARROLL JM, ROMERO MR, WATT FM: Suprabasal in-tegrin expression in the epidermis of transgenic mice results in developmental defects and a phenotype re-sembling psoriasis. Cell (1995) 83:957–968.
   PubMed Web of Science ®Google Scholar
• BULLARD DC, SCHARFFETTER-KOCHANEK K et al.: A polygenic mouse model of psoriasiform skin disease in CD18-deficient mice. Proc. Natl. Acad. Sci. USA (1996) 93:2116–2121.
   PubMed Web of Science ®Google Scholar
• CARROLL JM, CROMPTON T, SEERY JP, WATT FM: Trans-genic mice expressing IFNI in the epidermis have ec-zema, hair hypopigmentation, and hair loss. J. Invest. Dermatol. (1997) 108:412–422.
   PubMed Web of Science ®Google Scholar
• YANAGISAWA H, RICHARDSON JA, TAUROG JD, HAM-MER RE: Characterization of psoriasiform and alloge-neic skin lesions in HLA-B27 transgenic rats. Am. J. Pathol. (1995) 147:955–964.
   PubMed Web of Science ®Google Scholar
• SUNDBURG JP, BUGGESS D, SUNDBERG BA, BEAMER WG, SHULTZ LD: Epidermal dendritic cell population in the flaking skin mutant mouse. Immunol. Invest. (1993) 22:389–401.
   PubMed Web of Science ®Google Scholar
• SUNDBURG JP, KING LE et al.: Mouse mutations as ani-mal models and biomedical tools for dermatological research. J. Invest. Dermatol. (1996) 106:368–379.
   PubMed Web of Science ®Google Scholar
• SCHON MP, PARKER CM: Murine psoriasis-like disorder induced by naive CD4+ T cells. Nature Med. (1997) 3:183–188.
   PubMed Web of Science ®Google Scholar
• SWERLICK RA, CUMMINGHAM MW, HALL NK: Mono-clonal antibodies cross-reactive with group A strepto-cocci in normal and psoriatic skin. J. Invest. Dermatol (1986) 87:367–371.
   PubMed Web of Science ®Google Scholar
• MCFADDEN JP, QUINN DG, CAMP RDR: In vitro lympho-cytic response to streptococcal M protein in psoriasis. Biochem. Soc. Trans. (1991) 19:115.
   PubMedGoogle Scholar
• BAKER BS, BOKTH S, POWLES A: Group A streptococcalantigen-specific T-lymphocytes in guttate psoriatic le-sions. Br. J. Dermatol. (1993) 128:493–499.
   PubMed Web of Science ®Google Scholar
• AOKI S, YAOITA H, KITAJIMA Y: An elevated level ofautoantibodies against 48 to 50 Kd keratins in the skin of patients with psoriasis. J. Invest. Dermatol. (1989) 92:179–183.
   PubMed Web of Science ®Google Scholar
• SIGMUNDSDOTTIR H, SIGURGEIRSSON B, TROYE-BLOMBERG M, GOOD MF: Circulating T cells of patients with active psoriasis respond to streptococcal M-peptides sharing sequences with human epidermal keratins. Scand. j Immunol. (1997) 45:688–697.
   PubMed Web of Science ®Google Scholar
• NAUKKARINEN A, NICKOLOFF BJ, FARBER EM: Quantifi-cation of cutaneous sensory nerves and their sub-stance P content in psoriasis. J. Invest. Dermatol (1989) 92:126–129.
   PubMed Web of Science ®Google Scholar
• EEDY DJ, JOHNSTON CF, SHAW C: Neuropeptides in psoriasis: an immunohistochemical and radioimmu-noassay study. J. Invest. Dermatol. (1991) 96:434–438.
   PubMed Web of Science ®Google Scholar
• JOHANNSSON 0, HAN SW, ENHAMRE A: Altered cutane-ous innervation in psoriatic skin revealed by PGP 915 immunohistochemistry. Arch. Dermatol. Res. (1991) 238:519–523.
   Google Scholar
• FAVRE M, ORTH G, MAJEWSKI S et al.: Psoriasis: a possi-ble reservoir for human papillomavirus Type 5, the vi-rus associated with carcinomas of epidermodysplasia verciformis. J. Invest. Dermatol (1998) 110:311–317.
   PubMed Web of Science ®Google Scholar
• MAJEWSKI S, FAVRE M, ORTH G, JABLONSKA S: Is humanpapillomavirus Type 5 the putative autoantigen in-volved in psoriasis? J. Invest. Dermatol (1998) 111:541–542.
   PubMed Web of Science ®Google Scholar
• KAURMANN SHE: Heat shock proteins and the immuneresponse. Immunol. Today (1990) 11:129–136.
   PubMedGoogle Scholar
• MAYTIN EV: Heat shock proteins and molecular chap-erones: implications for adaptive responses in the skin. J Invest. Dermatol. (1995) 104:448–455.
   PubMed Web of Science ®Google Scholar
• GARDNER-EDWARDS R, MCCLAREN M, ISSEROFF RR: Im-munolocalization of low-molecular weight stress pro-tein HSP27 in normal skin and common cutaneous lesions. Am. J. Dermatopath. (1994) 16:504–509.
   PubMed Web of Science ®Google Scholar
• RAMBUKKANA A, DAS PK, KRREG S et al.: Mycobacterial 65,000 MW heat-shock protein shares a carboxy-terminal epitope with human epidermal cytokeratin 1/2. Immunol. (1992) 77:267–276.
   PubMed Web of Science ®Google Scholar
• PUIG L, FERNANDEZ-FIGUERAS MT, FERRANICIZ C, RIB-ERA M, MORAGAS JM: Epidermal expression of 65 and 72 Kd heat shock proteins in psoriasis and AIDs associ-ated psoriasiform dermatitis. J. Am. Acad. Dermatol (1995) 33:985–989.
   PubMed Web of Science ®Google Scholar
• AL-MASAUD AS, WOOD EJ, CUNLIFFE WJ: Antibodies to the 90kDa heat shock protein in chronic plaque pso-riasis. Acta. Derm. Venereol (1995) 75:317–319.
   PubMed Web of Science ®Google Scholar
• RAMBUKKANA A, DAS PK, WITKAMP L et al: Antibodies to mycobacterial 65-kDa heat shock protein and other immunodominant antigens in patients with psoriasis. J. Invest. Dermatol. (1993) 100:87–92.
   PubMed Web of Science ®Google Scholar
• JACKMAN RM, MOODY DB, PORCELLI SA: Mechanism of lipid antigen presentation by CD1. Grit. Rev. Immunol (1999) 19:49–63
   PubMed Web of Science ®Google Scholar
• NICKOLOFF BJ, WRONE-SMITH T: Injection of pre-psoriatic skin with CD4+ T-cells induces psoriasis. Am. J. Pathol. (In Press)
   Google Scholar
• IYER VR, EISEN MB, ROSS DT et al.: The transplantation program in the response of human fibroblasts to se-rum. Science (1999) 283:83–87.
   PubMed Web of Science ®Google Scholar